The BioTech Pharma Summit: Liquid Biopsy 2020 focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers. There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.
Dit zal plaatsvinden in Lissabon. Meer informatie kunt u vinden op de website.
RT @eshgsociety: Unfortunately #ESHG2020 in Berlin had to be cancelled due to the current situation. But “ESHG 2020.2 - Live in your living…
RT @UMCUgenetica: Vanwege de coronacrisis is de oratie van @jpvantintelen (gepland 8-4) uitgesteld / Because of the corona crisis the inaug…
RT @Sanne_tenBroeke: De vacature voor een promovendus op mijn nieuwe #KWF project #Lynch-GPS is open! Voor meer info en solliciteren kijk o…